Figure 3.
Therapeutic effects of BHGZD, two-BAC combination, and MTX on the severity of arthritis in AIA-M rats (Control, AIA-M, BHGZD, MG+CA, and MTX). (A) Representative images of arthritis. (B) Infrared thermography. (C) Arthritis incidence (n = 3 per group), the diameter of the limb (n = 5 per group), and arthritis score on the 27th day after immunization (n ≥ 4 per group, all experiments were performed in triplicate). (D) The pain thresholds (mechanical-, acetone-, and thermal-induced hyperalgesia, n ≥ 4 per group, all experiments were performed in triplicate). (E) Quantitative micro-computed tomography (micro-CT) analysis of bone mineral density (BMD), tissue mineral density (TMD), bone volume/tissue volume (BV/TV), bone surface/bone volume (BS/BV), trabecular separation (Tb.Sp), and trabecular thickness (Tb.Th) on the 31st day after immunization (n ≥ 5 per group, all experiments were performed in triplicate). (F) Representative micro-CT images of knee joints showing bone erosion levels (the red arrow indicates the position of the bone destruction). (G) Pathological changes in the knee joints using hematoxylin and eosin (H&E, scale bar represents 1 mm), safranin O fast green (scale bar represents 200 μm), and Masson trichrome staining (scale bar represents 200 μm) in different groups (n = 5 per group). (H) Quantitative analysis of H&E staining in inflammatory cell infiltration, bone destruction, and synovial hyperplasia. Cartilage destruction of safranin O fast, and Masson trichrome staining (n = 5 per group). Data are expressed as the mean ± SD. ***, p < 0.001, comparison with the normal control group; #, ##, ###, p < 0.05, p < 0.01, p < 0.001, respectively, comparison with the AIA-M model group.